Is Homeodynamics, LLC Safe? FDA Warning Letter Review (2018)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on February 20, 2018
Executive Summary
The FDA issued a warning letter to Homeodynamics, LLC on February 20, 2018 citing regulatory violations. The letter was issued by Minneapolis District Office.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in Homeodynamics, LLC's operations or product claims.
Potential Health Risks
Your Aids Nosodinum product label bears the statement “* Daily Value not established,” but the asterisk does not refer to any dietary ingredient.
Regulatory Context
The net quantity of contents declaration on your Carcinoma Mammae and Aids Nosodinum product labels must be placed within the bottom 30% of the principal display panel, 21 CFR 101.7.
Your Ninox Sculata, Multiple Sclerosis Nosode, Aids Nosodinum, and Botulinum product labels list terms that are not permitted within the Supplement Facts label. For example: “organic.”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Homeodynamics, LLC?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Homeodynamics, LLC products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Homeodynamics, LLC products?
- If you have used products from Homeodynamics, LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter